当前位置:首页 > 文献互助 > 互助详情

Radiopharmaceuticals: Status, Regulatory Landscape and Future Perspective复制

用户sToGMn7iJdc8 8小时前 8 10 求助中 帖子自动结束时间: 2026-03-18 19:36:50

1. 文件大小不能超过300M, 允许上传文档或压缩包等

2. 请确保上传文献的真实性、完整性,不得对原文做任何修改

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI:复制

文献链接:复制

其他信息:

H Maithania, R John, R Painoori…
AAPS …, 2026
pubmed.ncbi.nlm.nih.gov
Radiopharmaceuticals are biologically active molecules labeled with radionuclides that have advanced the possibility of the nuclear medicine. They support non-invasive, high-resolution diagnostic imaging of molecular and physiological processes in vivo. The techniques such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT) utilize short-lived β⁺ and γ-emitting isotopes to generate highly sensitive, three-dimensional assessments of biological function. In therapeutic …

互助时间线

2026-03-13 19:36:50 [发起求助]